Urinary incontinence
Incontinence · Gynaecology
Physician-written · Verified by three sets of doctors · Reviewed November 2026
Bedside summary
Female urinary incontinence is categorised mainly as stress, urgency or mixed. Conservative measures (pelvic floor training, bladder retraining) are first-line, with drug and surgical options reserved for those who do not respond.
Red flags
- Visible haematuria (needs urgent urology referral)
- Recurrent urinary tract infection
- Palpable bladder/retention
- Pelvic mass
- Suspected fistula (continuous leakage after surgery or obstetric injury)
Assessment
Differential diagnosis
- Stress urinary incontinence
- Urgency incontinence (overactive bladder)
- Mixed incontinence
- Overflow incontinence (retention)
- Fistula
- Urinary tract infection
Investigations
- Urinalysis and culture to exclude infection
- Bladder diary over at least 3 days
- Post-void residual volume assessment
- Assessment of pelvic floor and prolapse on examination
- Urodynamics before surgery or when the diagnosis is unclear
- Symptom and quality-of-life questionnaires
Management
- Categorise incontinence by history and bladder diary
- Exclude infection, retention and significant prolapse
- Advise lifestyle measures: weight loss, caffeine reduction and fluid management
- Offer supervised pelvic floor muscle training for at least 3 months as first-line for stress incontinence
- Offer bladder retraining as first-line for urgency incontinence
- Add antimuscarinic or beta-3 agonist drugs for persistent overactive bladder
- Consider duloxetine for stress incontinence where surgery is declined or unsuitable
- Refer for specialist and surgical options if conservative measures fail
- Review and manage treatment side effects, especially in older women
Drugs & doses
Oxybutynin, tolterodine or solifenacin (antimuscarinics) for overactive bladder
Mirabegron (beta-3 agonist) as an alternative, useful where anticholinergic load is a concern
Duloxetine 40 mg PO twice daily for stress incontinence (second-line)
Vaginal oestrogen for urogenital atrophy in postmenopausal women
Disposition
Manage conservatively in primary care; refer to urogynaecology for refractory symptoms, diagnostic uncertainty, or surgical consideration, and urology for haematuria.
Complications & pitfalls
- Social isolation and reduced quality of life
- Skin breakdown
- Recurrent infection
- Anticholinergic side effects, including cognitive effects in older women
- Surgical complications (mesh-related issues)
Exam pearls
- Supervised pelvic floor training works and should be tried for at least 3 months before surgery
- Mirabegron avoids the anticholinergic burden of antimuscarinics in frail or older women
- Visible haematuria mandates urgent referral to exclude malignancy
- Continuous leakage after pelvic or obstetric surgery suggests a fistula
Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.